Rapt Therapeutics Inc
NASDAQ:RAPT

Watchlist Manager
Rapt Therapeutics Inc Logo
Rapt Therapeutics Inc
NASDAQ:RAPT
Watchlist
Price: 36.8 USD 4.31% Market Closed
Market Cap: 1B USD

Net Margin
Rapt Therapeutics Inc

0%
Current
-1 487%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-105.6m
/
Revenue
0

Net Margin Across Competitors

No Stocks Found

Rapt Therapeutics Inc
Glance View

Market Cap
1B USD
Industry
Biotechnology

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company. The company is headquartered in South San Francisco, California and currently employs 81 full-time employees. The company went IPO on 2019-10-31. The firm is focused on discovering, developing and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Utilizing its drug discovery and development engine, the Company develops selective small molecules that are designed to modulate the critical immune responses underlying these diseases. Its two lead drug candidates each target C-C motif chemokine receptor 4 (CCR4). Its lead oncology drug candidate, FLX475, is designed to selectively inhibit the migration of immunosuppressive regulatory T cells (Treg) into tumors. FLX475 is in Phase I/II clinical trials. Its lead inflammation drug candidate, RPT193, is designed to selectively inhibit the migration of type 2 T helper cells (Th2 cells) into inflamed tissues.

RAPT Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-105.6m
/
Revenue
0
What is the Net Margin of Rapt Therapeutics Inc?

Based on Rapt Therapeutics Inc's most recent financial statements, the company has Net Margin of 0%.

Back to Top